In contrast, cross-sectional studies on its impact on circulating insulin-like growth factor 1 (IGF-1) revealed conflicting results, by showing unchanged [6–8], decreased [9, 10] or even increased concentrations [11, 12] in lean humans compared with people with obesity. Here, IGF1 is linked to obesity disorder.